Dados B3 › TIMS3 × OIBR3
TIMS3 × OIBR3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | TIMS3 | OIBR3 | year |
|---|---|---|---|
| ROE | 12.2%! | -243.5% | 2021 |
| ROIC | 13.7% | -91.3%! | 2022 |
| ROA | 5.7%! | 41.9%! | 2024 |
| Gross margin | 53.3%! | -45.7%! | 2024 |
| EBIT margin | 21.6%! | -61.5%! | 2024 |
| Net margin | 12.4%! | 302.2%! | 2024 |
| Net debt/EBITDA | -0.63x | 11.73x | 2021 |
| Current ratio | 0.99x! | 1.00x! | 2024 |
| Revenue growth (1y) | 6.8%! | -25.3%! | 2024 |
| Revenue growth (5y CAGR) | 7.9%! | -21.2%! | 2024 |
| Piotroski F-Score | 8/9! | 5/9! | 2024 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | TIMS3 | OIBR3 | year |
|---|---|---|---|
| P/E | 14.40x | 0.00x | 2025 × 2024 |
| P/B | 2.59x | — | 2025 × 2024 |
| EV/EBITDA | 4.39x | — | 2025 × 2024 |
| FCF yield | 14.3% | -352,559.1% | 2025 × 2024 |
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:37 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.
Numbers on this page are live. Data version 2026-09-27-reapresentacao-agreg · page generated 2026-09-27 08:37 UTC. If this does not match /saude, you are reading a cached copy.